https://lnkd.in/gDPQx9Gw
The IDH1 mutant inhibitor, a tricyclic diazepine functionalized with a zigzag morphorine and chiral cyclohexyl acid, was required in kilogram-scale quantities for clinical trials. The diazepine core was synthesized via Pd-catalyzed C-N coupling, followed by Boc protection and reductive cyclization. The use of Pt-V/C for reduction was the key to keep the chloro group intact while reducing the nitro group and subsequently formed imine in one-pot. The core was then acylated with an acyl chloride derived from the chiral cyclohexyl acid in MeCN, and isolated through water quenching at low temperature with seeding. Subsequently, the zigzag morphorine was coupled with the acylated core under Pd-catalytic conditions, and Boc deprotection was performed with MsOH to yield the final product. Additionally, they demonstrated dynamic mono-acylation of unprotected diazepines, where the acyl group on the undesired N11 group was selectively transferred to the desired N6 position at elevated temperatures without the need for an external base.
Senior Consultant in Pharmaceutical Industry: SME for Project Management in Quality, Technical, Regulatory Affairs (tech transfers and brand/product improvement programs, post-approval life cycle management).
8moMabrooooooook Ya sadeiky